LauraL.(Melendres)KothMD
Pulmonology • San Francisco, CAPleural Disease
Assistant Professor, Medicine, UCSF School of Medicine
Dr. Koth is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
400 Parnassus Ave
San Francisco, CA 94143Phone+1 415-353-2961Fax+1 415-353-2568
Education & Training
Massachusetts General HospitalResidency, Internal Medicine, 1994 - 1997
Harvard Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 1998 - 2025
MA State Medical License 1996 - 1999- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Genomic Research in Sarcoidosis Start of enrollment: 2013 May 01
- Genomic Research in Alpha-1 Antitrypsin Deficiency Start of enrollment: 2013 May 01
- Use of CXCL9 as a Biomarker of Acthar Efficacy Start of enrollment: 2022 Nov 03
- Join now to see all
Publications & Presentations
PubMed
- 67 citationsLong-Term Corticosteroid-Sparing Immunosuppression for Cardiac Sarcoidosis.David G. Rosenthal, Purvi Parwani, Tyler Murray, Bradley J. Petek, Bryan S. Benn
Journal of the American Heart Association. 2019-09-17 - 1273 citationsT-helper Type 2–driven Inflammation Defines Major Subphenotypes of AsthmaPrescott G. Woodruff, Barmak Modrek, David F. Choy, Guiquan Jia, Alexander R. Abbas
American Journal of Respiratory and Critical Care Medicine. 2009-09-01 - 363 citationsThe WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical toolMarc A. Judson, Ulrich Costabel, Marjolein Drent, Athol U. Wells, Lisa A. Maier
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases. 2014-04-18
Grant Support
- Genomic Phenotyping And Mechanisms In Sarcoidosis And AATNational Heart, Lung, And Blood Institute2012
- Immunophenotyping And Lymphocyte Effector Functions In SarcoidosisNational Institute Of Allergy And Infectious Diseases2010
- Effector Function Of Natural Killer T (NKT) Cells In SarcoidosisNational Institute Of Allergy And Infectious Diseases2009–2010
- MCP-1 And TGFB In Macrophage Activation And EmphysemaNational Heart, Lung, And Blood Institute2003–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
